Your Source for Venture Capital and Private Equity Financings

Select An Article

Cayenne Medical Closes $10M
2012-02-14
SCOTTSDALE, AZ, Private sports medicine device company announced the closing of a $10 million equity financing, with new investor Fletcher Spaght Ventures joining existing investors Split Rock Partners, MB Venture Partners and Investor Growth Capital.
Read More
IM+ Grabs $10M from Russians
2012-02-14
STUTTGART, GERMANY, Mobile messenger service raised $10M from Finam, the largest Russian brokerage and investment holding, which previously invested in Badoo and other web companies.
Read More
Oxitec Secures 8M British Pounds
2012-02-14
OXFORD, ENGLAND, British company pioneering a new approach to combating dengue fever, announced today that it has secured 8 million pounds of new investment. The funding round was led by specialist investment manager Oxford Capital.
Read More
DoubleRecall Secures $1.6M
2012-02-14
NEW YORK, NY, DoubleRecall, the YCombinator (YC) backed startup received $1.6 million in funding from investors in Silicon Valley.
Read More
SpaceCurve Inks $2.7M
2012-02-14
SEATTLE, WA, SpaceCurve raised $2.7 million to fund the development of big data solutions that address growing market demands for real-time location-based services. Investors in the financings include Reed Elsevier Ventures, Divergent Ventures and Musea Ventures.
Read More
InnaVirVax Receives $4.9M Series B
2012-02-14
EVRY, FRANCE, Biopharmaceutical company dedicated to the development of therapeutic and diagnostic solutions in pathologies associated with immune dysregulation, announced the closing of a $4.9 million.
Read More
LiveClips Receives Additional $2.15M
2012-02-14
STAMFORD, CT, Innovator and pioneer in the creation, digitization and real-time delivery of smart video clips to sports and fantasy league fans, received new investments totaling $2.15 million over the past two months.
Read More
Avaxia Biologics Closes $4.1M Series A
2012-02-14
LEXINGTON, MA, Privately-held biotech company developing oral antibody drugs that act locally within the gastrointestinal tract, announced that the company completed its $4.1 million Series A angel-led financing.
Read More
ViSenze Gets $3.5M Series A
2012-02-14
SINGAPORE, ViSenze has closed a $3.5 million Series A financing.
Read More